These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 7996065)
1. Hyperglycemia, ketoacidosis and other complications of L-asparaginase in children with acute lymphoblastic leukemia. Cetin M; Yetgin S; Kara A; Tuncer AM; Günay M; Gümrük F; Gürgey A J Med; 1994; 25(3-4):219-29. PubMed ID: 7996065 [TBL] [Abstract][Full Text] [Related]
2. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296. Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607 [TBL] [Abstract][Full Text] [Related]
3. L-asparaginase related hyperglycemia. Iyer RS; Rao SR; Pai S; Advani SH; Magrath IT Indian J Cancer; 1993 Jun; 30(2):72-6. PubMed ID: 8225380 [TBL] [Abstract][Full Text] [Related]
4. [Hyperglycemia as a side effect of using L-asparaginase in children with acute lymphoblastic leukemia (ALL]. Brodkiewicz A; Kamieńska E; Urasiński T; Peregud-Pogorzelski J Acta Haematol Pol; 1995; 26(1):99-101. PubMed ID: 7747569 [TBL] [Abstract][Full Text] [Related]
5. Erwinia- and E. coli-derived L-asparaginase have similar effects on hemostasis. Pilot study in 10 patients with acute lymphoblastic leukemia. Castaman G; Rodeghiero F Haematologica; 1993; 78(6 Suppl 2):57-60. PubMed ID: 8039761 [TBL] [Abstract][Full Text] [Related]
6. Diabetic ketoacidosis with L-asparaginase therapy. Mondal R; Nandi M; Tiwari A; Chakravorti S Indian Pediatr; 2011 Sep; 48(9):735-6. PubMed ID: 21992909 [TBL] [Abstract][Full Text] [Related]
7. Conservative treatment of L-asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. Cohen H; Bielorai B; Harats D; Toren A; Pinhas-Hamiel O Pediatr Blood Cancer; 2010 May; 54(5):703-6. PubMed ID: 20063421 [TBL] [Abstract][Full Text] [Related]
8. [Results of the CCLSG high risk ALL 874 protocol in childhood acute lymphoblastic leukemia. Children's Cancer and Leukemia Study Group]. Kawai S; Fujimoto T; Zha Z; Asami K; Oka T; Kaneko Y; Takaue Y; Ninomiya T; Nishikawa K; Tsuchiya T Rinsho Ketsueki; 1993 Feb; 34(2):128-36. PubMed ID: 8492409 [TBL] [Abstract][Full Text] [Related]
9. Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study. Heath JA; Steinherz PG; Altman A; Sather H; Jhanwar S; Halpern S; Pieters R; Shah N; Steinherz L; Tannous R; Terry W; Trigg ME; J Clin Oncol; 2003 Apr; 21(8):1612-7. PubMed ID: 12697887 [TBL] [Abstract][Full Text] [Related]
10. Acute lymphoblastic leukemia in infants. Gürgey A; Yetgin S; Cetin M; Gümrük F; Tuncer AM; Tunçbilek E; Hiçsönmez G Turk J Pediatr; 2004; 46(2):115-9. PubMed ID: 15214738 [TBL] [Abstract][Full Text] [Related]
12. A desensitization protocol in children with L-asparaginase hypersensitivity. Akbayram S; Doğan M; Akgün C; Caksen H; Oner AF J Pediatr Hematol Oncol; 2010 Jul; 32(5):e187-91. PubMed ID: 20505537 [TBL] [Abstract][Full Text] [Related]
13. Hypersensitivity reactions to L-asparaginase do not impact on the remission duration of adults with acute lymphoblastic leukemia. Larson RA; Fretzin MH; Dodge RK; Schiffer CA Leukemia; 1998 May; 12(5):660-5. PubMed ID: 9593262 [TBL] [Abstract][Full Text] [Related]
14. Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia. Pession A; Valsecchi MG; Masera G; Kamps WA; Magyarosy E; Rizzari C; van Wering ER; Lo Nigro L; van der Does A; Locatelli F; Basso G; Aricò M J Clin Oncol; 2005 Oct; 23(28):7161-7. PubMed ID: 16192600 [TBL] [Abstract][Full Text] [Related]
15. L-asparaginase as a marker of chemotherapy dose modification in children with acute lymphoblastic leukemia. Baillargeon J; Langevin AM; Lewis M; Thomas PJ; Mullins J; Dugan J; Pollock BH Cancer; 2005 Dec; 104(12):2858-61. PubMed ID: 16288492 [TBL] [Abstract][Full Text] [Related]
16. Retherapy using L-asparaginase with octreotide in a patient recovering from L-asparaginase-induced pancreatitis. Suzuki M; Takata O; Sakaguchi S; Fujimura J; Saito M; Shimizu T Exp Hematol; 2008 Mar; 36(3):253-4. PubMed ID: 18279714 [No Abstract] [Full Text] [Related]
17. [Long-term infusion of L-asparaginase--an alternative to intramuscular injection?]. Rodriguez T; Baumgarten E; Fengler R; Soumpasis D; Henze G Klin Padiatr; 1995; 207(4):207-10. PubMed ID: 7564153 [TBL] [Abstract][Full Text] [Related]
19. [A case of ALL complicated with acute pancreatitis and pancreatic pseudocyst caused by L-asparaginase ]. Yasui I; Shimokawa T; Kasai M; Yamada H; Watanabe E; Takeyama H; Satake T Gan To Kagaku Ryoho; 1993 Jan; 20(1):149-52. PubMed ID: 8422180 [TBL] [Abstract][Full Text] [Related]
20. Thrombotic effects of asparaginase in two acute lymphoblastic leukemia protocols (NOPHO ALL-1992 versus NOPHO ALL-2000): a single-institution study. Ruud E; Holmstrøm H; de Lange C; Natvig S; Albertsen BK; Wesenberg F Pediatr Hematol Oncol; 2006; 23(3):207-16. PubMed ID: 16517537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]